カテゴリ： GlobalData, アメリカ, 企業調査

CVS Health Corp (CVS)：製薬・医療：M&Aディール及び事業提携情報

◆英語タイトル：CVS Health Corp (CVS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード：DATA904C10069
◆発行会社（調査会社）：GlobalData
◆発行日：2018年11月
◆ページ数：88
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：アメリカ
◆産業分野：製薬・医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD250 ⇒換算￥37,000見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD500 ⇒換算￥74,000見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD750 ⇒換算￥111,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※GlobalData社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Summary
CVS Health Corporation (CVS) is an integrated prescription and related health services provider. The company offers a range of solutions such as prescription medications; health care products; popular beauty, health and personal care brands; retail-based health clinical services; and pharmacy benefit management services. It also offers stand-alone Medicare Part D prescription drug plan.CVS operates several retail pharmacy units and walk-in health care clinics, serving plan membersacross the US. In addition to the physical pharmacy stores, the company operates online retail pharmacy through, CVS.com, Navarro.com, and Onofre.com.br.It operates medical clinics in the US, Puerto Rico, and District of Columbia. CVS is headquartered in Woonsocket, Rhode Island, the US.

CVS Health Corp (CVS) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
CVS Health Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
CVS Health Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
CVS Health Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
CVS Health Corp, Medical Devices Deals, 2012 to YTD 2018 9
CVS Health Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
CVS Health Corp, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
CVS Health to Acquire Pharmacy and Clinic Business from Target Corp for USD1.9 Billion 11
Omnicare Acquires Pharmacy Business Of Five Star Quality Care For US$39 Million 13
CVS Caremark Completes Acquisition Of Medicare PDP Business From Health Net For US$160 Million 14
Partnerships 15
CVS Caremark Forms Joint Venture With Cardinal Health 15
Acquisition 16
CVS Health Acquires Omnicare for USD12.9 Billion 16
CVS Caremark Completes Acquisition Of Coram From Apria Healthcare For US$2.1 Billion 18
CVS Caremark Acquires Drogaria Onofre, Distributor Of Healthcare Products 19
CVS Health Corp – Key Competitors 20
CVS Health Corp – Key Employees 21
CVS Health Corp – Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Joint Venture 24
Recent Developments 25
Financial Announcements 25
Aug 08, 2018: CVS Health reports second quarter 2018 results 25
May 02, 2018: CVS Health Reports First Quarter Results And Confirms 2018 Full Year Outlook 27
Feb 08, 2018: CVS Health Reports Fourth Quarter Results And Updates 2018 Full-year Outlook For Investments From Tax Reform 29
Jan 04, 2018: CVS Health Provides 2018 Outlook 32
Nov 06, 2017: CVS Health Reports Third Quarter Results 33
Aug 08, 2017: CVS Health Reports Second Quarter Results 35
May 02, 2017: CVS Health Reports First Quarter Results; Confirms 2017 EPS Guidance 37
Feb 09, 2017: CVS Health Reports Record Fourth Quarter And Full Year Results For 2016; Confirms 2017 EPS Guidance 39
Corporate Communications 40
Aug 02, 2018: CVS Health commits $10 million to American Cancer Society in support of Cancer Patient Services and breakthrough research 40
Jul 25, 2018: CVS Health and Truth Initiative challenge all women’s colleges to go tobacco-free 41
Jun 06, 2018: CVS Health Announces Management Team for Combined Company Following Close of Aetna Acquisition Transaction 42
Apr 16, 2018: CVS Health Appoints Kevin Hourican as President of CVS Pharmacy 44
Apr 13, 2018: CVS Health Names Marc-David Munk, MD, MPH, MHCM, as Chief Medical Officer of MinuteClinic and Associate Chief Medical Officer of CVS Health 45
Feb 10, 2018: CVS Health provides update to Board and Management roles upon closing of Aetna Acquisition 46
Mar 02, 2017: CVS Health Names Jon Roberts Executive Vice President and Chief Operating Officer 48
Legal and Regulatory 49
Aug 08, 2017: NASP Responds to New Class-Action Lawsuit Filed Against CVS Health Alleging Collusion with PBMs 49
Aug 07, 2017: Hagens Berman: Class-Action Lawsuit Says CVS Fraudulently Overcharges Consumers for Generic Prescription Drugs in Undisclosed Scheme 50
Government and Public Interest 52
Apr 11, 2018: CVS Health Fights Back on High Cost Drugs by Launching Industry’s Most Comprehensive Approach to Saving Patients Money 52
Mar 29, 2018: CVS Health Announces $260,000 in New Support for Bleeding Disorder Programs 54
Mar 01, 2018: CVS Health Foundation Increases Access to Health Care Across the Country with $1 Million in New Grants 55
Dec 14, 2017: CVS Health Foundation Announces Grant to Increase Access to Provider Education and Diagnosis Program for Alzheimer’s Disease 56
Apr 03, 2017: CVS Health Foundation Awards over $1 Million in Grants to Improve Americans’ Access to Quality Health Care 57
Product News 58
Nov 30, 2017: Meningitis B Vaccine Available to Students, Faculty and Staff at UMass Amherst 58
Nov 09, 2017: CVS Health Makes Overdose-Reversal Drug Available Without Individual Prescription at CVS Pharmacy Locations in Delaware 59
Aug 07, 2018: Product Quest Manufacturing issues voluntary nationwide recall of CVS Health 12 Hour Sinus Relief Nasal Mist due to microbiological contamination 60
Jul 27, 2017: CVS Health Makes Overdose-Reversal Drug Available Without Individual Prescription at CVS Pharmacy Locations in South Dakota 61
Other Significant Developments 62
Oct 31, 2018: CVS Health offering free Wellness Screenings in Boston 62
Oct 31, 2018: CVS Pharmacy pilots new CarePass program in Boston market 63
Oct 24, 2018: CVS Health to install 1,100 additional safe Medication Disposal Units and Expand Youth Opioid Abuse Prevention Program 64
Oct 16, 2018: CVS Health launches diabetes pilot project in Atlanta 65
Oct 10, 2018: CVS Pharmacy completes Rollout of Time Delay Safes in all California Stores 66
Sep 25, 2018: CVS Health announces commitment to build healthier communities in Ohio 67
Aug 14, 2018: Cvs health statement on ohio department of medicaid’s pass-through pricing requirements 68
Jul 16, 2018: CVS Health Responds to Request for Information on Trump Administration’s Blueprint to Lower Drug Prices 69
Jun 20, 2018: CVS Health Expands Safe Drug Disposal at CVS Pharmacy Locations in Arizona to Help Combat Opioid Abuse 72
May 08, 2018: Buoy Health and CVS Health Provide Easy Access to Affordable Care 73
Apr 19, 2018: CVS Health Expands Safe Drug Disposal at CVS Pharmacy Locations in Ohio to Help Combat Opioid Abuse 74
Apr 11, 2018: CVS Health Fights Back on High Cost Drugs by Launching the Industry’s Most Comprehensive Approach to Saving Patients Money 75
Apr 05, 2018: CVS Health Kept Drug Price Growth Nearly Flat and Improved Medication Adherence for PBM Clients in 2017 77
Mar 06, 2018: CVS Health Expands Safe Drug Disposal at CVS Pharmacy Locations in Rhode Island to Help Combat Opioid Abuse 78
Feb 05, 2018: MinuteClinic Providing No Cost “Know Your Numbers” Screenings Every Wednesday in February at All California Locations 79
Jan 23, 2018: CVS Health Expands Safe Drug Disposal at CVS Pharmacy Locations in South Carolina to Help Combat Opioid Abuse 80
Jan 17, 2018: CVS Health Launches New Transform Rheumatoid Arthritis Care Program to Improve Clinical Outcomes and Lower Pharmacy Costs 81
Nov 28, 2017: CVS Health Launches “Real-Time Benefits,” Providing Access to Actionable Information Across All Points of Care 82
Nov 02, 2017: CVS Health Offering Hepatitis A Vaccine to Broward County Residents Following Increase in Local Cases of the Illness 83
Oct 25, 2017: CVS Health Introduces Safe Medication Disposal Inside CVS Pharmacy, Marking National Prescription Drug Take Back Day 84
Oct 24, 2017: CVS Health Introduces New PBM Performance-based Pharmacy Network Focused on Reducing Costs and Improving Clinical Outcomes 85
Oct 23, 2017: Blink Health to Continue Providing Affordable Access to Patients Currently Using Blink Health’s Service at CVS Pharmacies 86
Mar 16, 2017: CVS Health Launches Reduced Rx Savings Program to Give Patients Access to More Affordable Medications 87
Appendix 88
Methodology 88
About GlobalData 88
Contact Us 88
Disclaimer 88

List of Tables
CVS Health Corp, Pharmaceuticals & Healthcare, Key Facts, 2017 2
CVS Health Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 2
CVS Health Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
CVS Health Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
CVS Health Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
CVS Health Corp, Medical Devices Deals, 2012 to YTD 2018 9
CVS Health Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
CVS Health to Acquire Pharmacy and Clinic Business from Target Corp for USD1.9 Billion 11
Omnicare Acquires Pharmacy Business Of Five Star Quality Care For US$39 Million 13
CVS Caremark Completes Acquisition Of Medicare PDP Business From Health Net For US$160 Million 14
CVS Caremark Forms Joint Venture With Cardinal Health 15
CVS Health Acquires Omnicare for USD12.9 Billion 16
CVS Caremark Completes Acquisition Of Coram From Apria Healthcare For US$2.1 Billion 18
CVS Caremark Acquires Drogaria Onofre, Distributor Of Healthcare Products 19
CVS Health Corp, Key Competitors 20
CVS Health Corp, Key Employees 21
CVS Health Corp, Other Locations 23
CVS Health Corp, Subsidiaries 23
CVS Health Corp, Joint Venture 24

List of Figures
CVS Health Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
CVS Health Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
CVS Health Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
CVS Health Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
CVS Health Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
CVS Health Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
CVS Health Corp, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[CVS Health Corp (CVS)：製薬・医療：M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Cadent Therapeutics：製薬・医療：M&Aディール及び事業提携情報
    Summary Cadent Therapeutics (Cadent), formerly Luc Therapeutics Inc, is a precision neuroscience company that offers medicines for serious neurological diseases. The company's products comprise NR2B positive allosteric modulators, NR2A negative allosteric modulators and NR2B negative allosteric modu …
  • Aura Light International AB：企業の戦略的SWOT分析
    Aura Light International AB - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Pedernales Electric Cooperative, Inc.：企業の発電所・SWOT分析2018
    Pedernales Electric Cooperative, Inc. - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, informatio …
  • Champions Oncology Inc (CSBR)：製薬・医療：M&Aディール及び事業提携情報
    Summary Champions Oncology Inc (Champions), formerly Champions Biotechnology Inc, is a developer of advanced technology solutions and services to personalize the development and use of oncology drugs. The company’s technology platform is an approach based upon the implantation of primary human tumor …
  • Sonoco Products Co (SON)：企業の財務・戦略的SWOT分析
    Sonoco Products Co (SON) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • New Carolin Gold Corp：企業の戦略・SWOT・財務情報
    New Carolin Gold Corp - Strategy, SWOT and Corporate Finance Report Summary New Carolin Gold Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Orbis Biosciences Inc：製薬・医療：M&Aディール及び事業提携情報
    Summary Orbis Biosciences Inc (Orbis) is a developer of pharmaceutical products that offers optimizes oral and injectable products. The company provides preclnical pipeline indications for pathologies including cancer, bronchiolitis, Eczema, atopic dermatitis, nephrotic syndrome, HIV, asthma, bunine …
  • Brooks Automation Inc (BRKS)：企業の財務・戦略的SWOT分析
    Brooks Automation Inc (BRKS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Renault SA：企業の戦略・SWOT・財務情報
    Renault SA - Strategy, SWOT and Corporate Finance Report Summary Renault SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • New York Power Authority：発電所・企業SWOT分析
    New York Power Authority - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key empl …
  • Occidental Chemical Corp：企業の戦略的SWOT分析
    Occidental Chemical Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Cristal Therapeutics BV：製薬・医療：M&Aディール及び事業提携情報
    Summary Cristal Therapeutics BV (Cristal Therapeutics) is a pharmaceutical company that develops nano-medicines for the treatment of cancer and chronic inflammatory disorders. The company develops CriPec docetaxel, a lead product candidate for solid tumours. It also provides peptide-based products, …
  • Banco Nacional de Obras y Servicios Publicos SNC：企業の戦略・SWOT・財務情報
    Banco Nacional de Obras y Servicios Publicos SNC - Strategy, SWOT and Corporate Finance Report Summary Banco Nacional de Obras y Servicios Publicos SNC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, …
  • MEDICREA Group (ALMED)：医療機器：M&Aディール及び事業提携情報
    Summary MEDICREA Group (MEDICREA) is a medical equipment company that provides surgical solutions to neurosurgeons and orthopedic surgeons. The company designs, manufactures and distributes proprietary technologies related to patient specific spinal surgery. It offers products such as polyaxial spin …
  • Land Securities Group Plc：企業のM&A・事業提携・投資動向
    Land Securities Group Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Land Securities Group Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisi …
  • Arab Petroleum Investments Corp：企業の戦略的SWOT分析
    Arab Petroleum Investments Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Fujirebio Diagnostics Inc-医療機器分野：企業M&A・提携分析
    Summary Fujirebio Diagnostics Inc (FDI), a subsidiary of Fujirebio Inc is a healthcare diagnostic company that develops, manufactures and markets in-vitro diagnostic products and biomarker assays. The company’s products include manual kits, EIA kits, OEM custom solutions, multi-constituent controls, …
  • Hydro Ottawa Holding Inc：企業の戦略的SWOT分析
    Hydro Ottawa Holding Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Veracyte Inc (VCYT)：企業の財務・戦略的SWOT分析
    Summary Veracyte Inc (Veracyte) is a molecular diagnostics company that uses genomic technology to resolve diagnostic ambiguity. The company’s pipeline products include Afirma thyroid FNA analysis for the diagnosis of thyroid cancer based on its proprietary afirma gene expression classifier. It also …
  • Aviva plc：企業のM&A・事業提携・投資動向
    Aviva plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Aviva plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capita …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆